title: Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
authors.forename: R
authors.initials: R
authors.lastname: Martino
authors.forename: S
authors.initials: S
authors.lastname: Bretagne
authors.forename: M
authors.initials: M
authors.lastname: Rovira
authors.forename: A J
authors.initials: AJ
authors.lastname: Ullmann
authors.forename: J
authors.initials: J
authors.lastname: Maertens
authors.forename: T
authors.initials: T
authors.lastname: Held
authors.forename: E
authors.initials: E
authors.lastname: Deconinck
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D001782:Blood Donors; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control / Q000635:transmission; D011292:Premedication; D016036:Seroepidemiologic Studies; D014122:Toxoplasma / Q000276:immunology / Q000502:physiology; D014123:Toxoplasmosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control / Q000635:transmission; D014184:Transplantation, Homologous / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000913:Antibodies, Protozoan; D015662:Trimethoprim, Sulfamethoxazole Drug Combination